LEAMON CHRISTOPHER P (Vice President of Research) sold 11.8% of their position (17.37K shares) of ENDOCYTE INC on the open market
Open‑market sale worth $347.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+12.67K
Price / share
$2.54
Trade value
$32.18K
% of position
Common Stock
Shares
−12.67K
Price / share
$20.00
Trade value
$253.40K
% of position
Common Stock
Shares
+4.70K
Price / share
$2.54
Trade value
$11.93K
% of position
Common Stock
Shares
−4.70K
Price / share
$20.00
Trade value
$93.92K
% of position
Net shares
+0.00
Net value
-$303.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/28/2018 | M · Option Exercise | +12.67K | $2.54 | $32.18K | 9.7% | 130.38K | 143.05K |
| Common Stock Direct | 8/28/2018 | S · Sale | −12.67K | $20.00 | $253.40K | 8.9% | 143.05K | 130.38K |
| Common Stock Direct | 8/29/2018 | M · Option Exercise | +4.70K | $2.54 | $11.93K | 3.6% | 130.38K | 135.08K |
| Common Stock Direct | 8/29/2018 | S · Sale | −4.70K | $20.00 | $93.92K | 3.5% | 135.08K | 130.38K |
| Total | +0.00 | -$303.21K | ||||||
Stock Option (right to buy)
Common Stock
12.67K shares
Shares
−12.67K
Strike price
2.54
Held after
24.70K
Exercisable
—
Stock Option (right to buy)
Common Stock
4.70K shares
Shares
−4.70K
Strike price
2.54
Held after
20K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock12.67K shares | 8/28/2018 | M · Option Exercise | −12.67K | 2.54 | — | 24.70K |
| Stock Option (right to buy) Direct | Common Stock4.70K shares | 8/29/2018 | M · Option Exercise | −4.70K | 2.54 | — | 20K |